drugset / Trial / NCT00761020
Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection
Completed
31 enrolled
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR) · collab
Non-randomizedParallel-groupOpen-labelOther
Summary
The main purpose of this trial is to study whether a certain blood test can reliably identify the presence of malaria in people who have been infected with, but who do not have symptoms of malaria.
Timeline
- Start
- 2008-09
- Primary completion
- 2009-04
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mefloquine | Unknown | 250 mg | Oral |